Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
66 participants
OBSERVATIONAL
2008-10-31
2013-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment With Spinal Cord Stimulation: Effect on Sensory Parameters
NCT01261468
Spinal Cord Stimulation Research Study
NCT00737581
Spinal Cord Stimulation vs. Medical Management for Low Back Pain (DISTINCT)
NCT04479787
Study to Characterize Effects of Programming in SCS Patients Undergoing a Temporary Trial
NCT02988713
Spinal Cord Stimulation (SCS) Therapy Study
NCT02371122
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Candidate for SCS device trial
* Subject is ambulatory
* Diagnosed with low back pain or low back pain plus leg pain for at least 6 months
* Undergoing treatment for low back pain or low back pain plus leg pain
* Does not have or has not had a previous SCS implant
* Willing and able to complete protocol requirements
* Willing and able to sign the study-specific Informed Consent form
* Male or non-pregnant female
Exclusion Criteria
* Cancer or any other malignant disease
* Present or past diagnosis of schizophrenia or of delusional, psychotic, or dissociative disorder
* A pain-related surgery in the previous 12 weeks of enrollment, the intent to undergo surgery during the period of the study
* Non-English speaking or an inability to complete questionnaires accurately
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
MedtronicNeuro
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David M Schultz, MD
Role: PRINCIPAL_INVESTIGATOR
Medical Advanced Pain Specialists (MAPS)
Robert Jamison, Ph.D
Role: PRINCIPAL_INVESTIGATOR
Brigham and Women's Hospital
Eric Grigsby, M.D.
Role: PRINCIPAL_INVESTIGATOR
Napa Pain Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Napa Pain Institute
Napa, California, United States
Brigham and Women's Hospital
Chestnut Hill, Massachusetts, United States
Medical Advanced Pain Specialists (MAPS)
Edina, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1644
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.